What DEA form is used to dispense schedule 2 drugs for the Narcotic Treatment Program?

The correct answer is the form specifically designated for Narcotic Treatment Programs, which is Form 363. This form is crucial for the registration of facilities that intend to dispense narcotics for the treatment of substance use disorders, specifically when it comes to the controlled substances listed under Schedule II in the Controlled Substances Act. Form 363 is utilized when a program is seeking to be recognized as an entity capable of providing treatment with opiate agonists, such as methadone or buprenorphine, for individuals struggling with addiction.

In contrast, other forms serve different purposes. For example, Form 106 is used for reporting the theft or loss of controlled substances, while Form 222 is employed for ordering Schedule I and II controlled substances from suppliers. Form 30 is not relevant in this context, as it pertains to the reporting used for transferring narcotics from one facility to another but does not apply to dispensing within a treatment program. Understanding the specific use of these forms is essential for compliance with federal regulations regarding controlled substances in veterinary and medical practice.